Oxford Leuven Surgery Limited 4473610 false 2023-01-01 2023-12-31 2023-12-31 The principal activity of the company is the provision of medical services and consultancy Digita Accounts Production Advanced 6.30.9574.0 true 4473610 2023-01-01 2023-12-31 4473610 2023-12-31 4473610 bus:OrdinaryShareClass1 2023-12-31 4473610 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2023-12-31 4473610 core:CurrentFinancialInstruments 2023-12-31 4473610 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 4473610 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 4473610 bus:SmallEntities 2023-01-01 2023-12-31 4473610 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 4473610 bus:FilletedAccounts 2023-01-01 2023-12-31 4473610 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 4473610 bus:RegisteredOffice 2023-01-01 2023-12-31 4473610 bus:Director3 2023-01-01 2023-12-31 4473610 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 4473610 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 4473610 core:ParentEntities 2023-01-01 2023-12-31 4473610 countries:England 2023-01-01 2023-12-31 4473610 2022-01-01 2022-12-31 4473610 2022-12-31 4473610 bus:OrdinaryShareClass1 2022-12-31 4473610 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2022-12-31 4473610 core:CurrentFinancialInstruments 2022-12-31 4473610 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 4473610 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 4473610

Oxford Leuven Surgery Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2023

Oxford Leuven Surgery Limited

Contents

Balance Sheet | 1
Notes to the Financial Statements | 2 to 5

Oxford Leuven Surgery Limited

(Registration number: 4473610)
Balance Sheet as at 31 December 2023

| Note | 2023 £ | 2022 £
Fixed assets |  |  |
Other financial assets | 4 | 457,266 | 436,238
Current assets |  |  |
Debtors | 5 | 100 | 100
Cash at bank and in hand |  | 35,625 | 45,760
|  | 35,725 | 45,860
Creditors: Amounts falling due within one year | 6 | (243,959) | (261,213)
Net current liabilities |  | (208,234) | (215,353)
Total assets less current liabilities |  | 249,032 | 220,885
Creditors: Amounts falling due after more than one year | 6 | (174,033) | (170,603)
Net assets |  | 74,999 | 50,282
Capital and reserves |  |  |
Called up share capital | 7 | 100 | 100
Retained earnings |  | 74,899 | 50,182
Shareholders' funds |  | 74,999 | 50,282

For the financial year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 6 July 2026

......................................... R B S De Baere Director

Oxford Leuven Surgery Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
30 St Giles'
Oxford
OX1 3LE

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price.A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Oxford Leuven Surgery Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

4 | Other financial assets (current and non-current)

| 2023 £ | 2022 £
Non-current financial assets
Financial assets at cost less impairment | 457,266 | 436,238

5 | Debtors

| 2023 £ | 2022 £
Other debtors | 100 | 100
| 100 | 100

Oxford Leuven Surgery Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

6 | Creditors

Creditors: amounts falling due within one year

| 2023 £ | 2022 £
Due within one year |  |
Accruals and deferred income | 2,000 | 1,850
Other creditors | 241,959 | 259,363
| 243,959 | 261,213

Creditors: amounts falling due after more than one year

| 2023 £ | 2022 £
Due after one year |  |
Other non-current financial liabilities | 174,033 | 170,603

Oxford Leuven Surgery Limited

Notes to the Financial Statements for the Year Ended 31 December 2023

7 | Share capital

Allotted, called up and fully paid shares

| 2023 | 2022
| No. | £ | No. | £
Ordinary shares of £1 each | 100 | 100 | 100 | 100

8 | Related party transactions

Summary of transactions with parent

Saturnus AG a company incorporated in Luxembourg was the controlling party.
During 2016 Saturnus AG advanced funds of 180,000 Euros to the company.
The loan was repayable on 31st December 2021.The parent company has extended repayment beyond the end of December 2023.The amount of interest accrued on the loan at the 31st December 2023 was 20,729 Euros (2022:12,424 Euros)